The acquired antifouling biosensor has great efficacy for CD44 analysis with a linear range of 0.5 ng mL−1 to 500 ng mL−1 and is capable of highly sensitive and selective screening of CD44 and CD44-positive tumor cells in heterogeneous liquids [147]. This evidence concerns the gene CD44 and neoplasm.